Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Capricor Therapeutics, Inc. (CAPR) had Cash Flow from Investing Activities of $-154.64M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-33.94M |
|
-- |
|
-- |
|
$36.77M |
|
$-36.77M |
|
$2.83M |
|
$-33.94M |
|
$-33.86M |
|
$-33.94M |
|
$-33.94M |
|
$-33.94M |
|
$-33.86M |
|
$-36.77M |
|
$-36.60M |
|
57.43M |
|
57.43M |
|
$-0.59 |
|
$-0.59 |
|
| Balance Sheet Financials | |
$283.09M |
|
$28.50M |
|
$43.19M |
|
$326.28M |
|
$33.64M |
|
-- |
|
$13.94M |
|
$47.58M |
|
$278.70M |
|
$278.70M |
|
$278.70M |
|
57.66M |
|
| Cash Flow Statement Financials | |
$-29.25M |
|
|
Cash Flow from Investing Activities |
$-154.64M |
$1.47M |
|
$287.85M |
|
$105.42M |
|
$-182.43M |
|
$5.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.18% |
|
-12.18% |
|
-10.40% |
|
-12.18% |
|
$4.83 |
|
$-0.70 |
|
$-0.51 |
|